Phosphofructokinases Axis Controls Glucose-Dependent mTORC1 Activation Driven by E2F1.

Almacellas, Eugènia; Pelletier, Joffrey; Manzano, Anna; Gentilella, Antonio; Ambrosio, Santiago; Mauvezin, Caroline; Tauler, Albert

Almacellas, Eugènia; Pelletier, Joffrey; Manzano, Anna; Gentilella, Antonio; Ambrosio, Santiago; Mauvezin, Caroline; Tauler, Albert.

Afiliação

Almacellas E; Department of Biochemistry and Physiology, School of Pharmacy, University of Barcelona, Barcelona, Catalonia 08028, Spain; Laboratory of Cancer Metabolism, Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospital
Pelletier J; Laboratory of Cancer Metabolism, Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet del Llobregat, Barcelona, Catalonia 08908, Spain.
Manzano A; Biochemistry Unit, Physiological Sciences Department, Faculty of Medicine and Health Science, University of Barcelona (IDIBELL), Hospitalet del Llobregat, Barcelona, Catalonia 08907, Spain.
Gentilella A; Department of Biochemistry and Physiology, School of Pharmacy, University of Barcelona, Barcelona, Catalonia 08028, Spain; Laboratory of Cancer Metabolism, Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospital
Ambrosio S; Biochemistry Unit, Physiological Sciences Department, Faculty of Medicine and Health Science, University of Barcelona (IDIBELL), Hospitalet del Llobregat, Barcelona, Catalonia 08907, Spain.
Mauvezin C; Laboratory of Cancer Metabolism, Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet del Llobregat, Barcelona, Catalonia 08908, Spain. Electronic address: cmauvezin@idibell.cat.
Tauler A; Department of Biochemistry and Physiology, School of Pharmacy, University of Barcelona, Barcelona, Catalonia 08028, Spain; Laboratory of Cancer Metabolism, Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospital

iScience ; 20: 434-448, 2019 Oct 25.

Article em En | MEDLINE | ID: mdl-31627130